A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Incyte Corporation
Incyte Corporation
Gustave Roussy, Cancer Campus, Grand Paris
Pfizer
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Arizona
University of California, San Diego
Goethe University
M.D. Anderson Cancer Center
Karolinska Institutet
Universität des Saarlandes
Vinmec Research Institute of Stem Cell and Gene Technology
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Pfizer
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Pfizer
Boehringer Ingelheim
Xencor, Inc.
Zhejiang University
The First Affiliated Hospital of Soochow University
Children's Oncology Group
Calibr, a division of Scripps Research
M.D. Anderson Cancer Center
Novartis
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Novartis
University Hospital Southampton NHS Foundation Trust
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Nebraska
University of Nebraska
Stanford University
University of Nebraska
University of Nebraska
University of Nebraska
Masonic Cancer Center, University of Minnesota
University of Nebraska
Alliance for Clinical Trials in Oncology
Canadian Cancer Trials Group